SCHEMBL6805142

SCHEMBL6805142

CCc1cccc(CC)c1NC(=O)CN1CC=CC=C1C1=CCNCC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.41
KDM4E B2RXH2 1/20 0.41
MEN1 O00255 1/20 0.37
RAB9A P51151 1/20 0.37
KMT2A Q03164 1/20 0.37
CYP2C19 P33261 2/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
POLB P06746 3/20 0.37
MAPT P10636 2/20 0.36
TP53 P04637 1/20 0.36
ALOX15 P16050 1/20 0.34
TSHR P16473 1/20 0.34
HIF1A Q16665 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
CACNA1G O43497 1/20 0.34
NAMPT P43490 1/20 0.34
WNT3A P56704 1/20 0.33
HTR2C P28335 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6805208 0.83 MEN1 (0.40) KDM4EMEN1RAB9AKMT2APOLB
SCHEMBL7098810 0.82 DRD4 (0.35) ALDH1A1MEN1RAB9AKMT2APOLB
SCHEMBL6793606 0.80 MAPKAPK2 (0.45) ALDH1A1POLBMAPTTP53NAMPT
SCHEMBL6236536 0.79 MAPT (0.41) ALDH1A1KDM4EMEN1KMT2APOLB
SCHEMBL6800083 0.77 HTR6 (0.38) ALDH1A1MEN1RAB9AKMT2APOLB
SCHEMBL6805141 0.69 ALDH1A1 (0.39) ALDH1A1KDM4EMEN1RAB9AKMT2A
SCHEMBL6245879 0.68 TDP1 (0.34) ALDH1A1KDM4EMEN1RAB9AKMT2A
SCHEMBL6216349 0.68 TDP1 (0.34) ALDH1A1KDM4EMEN1RAB9AKMT2A
SCHEMBL6800731 0.67 HTR2C (0.46) ALDH1A1MEN1KMT2APOLBTP53
SCHEMBL9031169 0.66 ALDH1A1 (0.64) ALDH1A1KDM4EMEN1RAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040029887-A1 Acetamides and benzamides that are useful in treating sexual dysfunction ABBOTT LABORATORIES 2004-02-12 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040029887-A1 Acetamides and benzamides that are useful in treating sexual dysfunction CATSPER1, CYP19A1, PDE12 ALDH1A1 88/4885KDM4E 2903/4885MEN1 2828/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.